Redox has closed a $45 million Series D financing round, the company announced today.

“2020 will be seen as an inflection point in digital health, as necessity brought five years of innovation forward into a single year,” Redox CEO Luke Bonney said in a statement. “But we couldn’t have reached this point in our collective growth without the consistent dedication and creativity of our team, our customers and our partners.”

According to a release, Adams Street Partners led the round with participation from Avenir and existing investors Battery Ventures, 406 Ventures and RRE Ventures.

The funds will be used to accelerate product innovation, hire new talent and meet widespread demand for its health data integration platform.

To date, Redox has raised $95 million, it reported.